
CLU appoints John Nunes as permanent president

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Former CLU chief takes Antioch helm

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Port of Hueneme holds annual World Trade Week event

Two months after the Trump Administration announced 25% tariffs on passenger vehicles, the taxes’ impact on the Port of Hueneme remains to be seen, speakers said at the port’s May 16 World Trade Week event. “Today we’re looking at world trade and resiliency given all the developments in trade policy with tariffs and the like,” Read More →

MOU with India firm could help expand 101 biotech hub

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Summit addresses need for affordable farmworkers housing

The lack of affordable housing for Ventura County’s farmworkers was the focus of panel discussions at a May 8 program in Santa Paula. “We’re trying to bring awareness to local developers to keep their minds open to serving farmworkers in their projects,” Ken Trigueiro, who sits on the board of House Farm Workers, which put Read More →
FDA lifts clinical hold on Atara’s lead treatment

Thousand Oaks-based Atara Biotherapeutics received a bit of good news on May 5, after the U.S. Food and Drug Administration announced that it has lifted its hold on Atara’s active Investigational New Drug application for the Ebvallo program. Ebvallo, which is already approved in Europe and is used for transplant-related blood cancer, was placed on Read More →